[Phenotype of isoniazid acetylation and tolerance of antitubercular drugs]. 1988

F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko
October 1974, Archives of dermatology,
F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko
October 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko
April 1960, La Revue du praticien,
F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko
March 1987, Wiadomosci lekarskie (Warsaw, Poland : 1960),
F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko
July 1968, Annals of the New York Academy of Sciences,
F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko
January 1982, Revue francaise des maladies respiratoires,
F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko
November 1977, The Journal of antimicrobial chemotherapy,
F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko
October 1954, Nature,
F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko
January 1968, Annali dell'Istituto "Carlo Forlanini",
F T Gontsa, and L A Savina, and V P Tsurkan, and I P Kovalenko
December 1983, al-Maghrib al-tibbi. Maroc medical,
Copied contents to your clipboard!